David Smith

Mr. David V.
Smith is an Independent Director at Codexis, Inc. and a Strategic Advisor at Monterey Innovation Acquisition Corp.
He is on the Board of Directors at Acepodia Biotechnologies, Ltd., Neurelis, Inc. and Codexis, Inc. Mr. Smith was previously employed as an Independent Director by IO Biotech, Inc., a Chief Financial Officer & Executive Vice President by Five Prime Therapeutics, Inc., a Chief Operating Officer by IntegenX, Inc., an Independent Director by OncoGenex Pharmaceuticals, Inc., a Chief Financial Officer & Executive Vice President by Thoratec Corp., a CFO, Principal Accounting Officer, VP & Controller by Chiron Corp., a Chief Financial Officer & Vice President-Finance by Anergen, Inc., a Principal by Genentech, Inc., a Principal by International Business Machines Corp., and a Principal by Syntex Corp.
He also served on the board at Acepodia, Inc. (United States) and Perlegen Sciences, Inc. He received his undergraduate degree from Willamette University and an MBA from Golden Gate University.